StonvexLoading…
StonvexStonvexStonvexCore line items from CTVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.91B | $17.40B | $13.49B | $10.87B |
Operating Income | $858.00M | $1.69B | $2.22B | $2.59B |
Net Income | $720.00M | $1.09B | $1.65B | $1.97B |
EPS (Diluted) | $1.07 | $1.60 | $2.41 | $2.87 |
Total Assets | $42.72B | $42.84B | $42.20B | $41.76B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.96B | $4.52B | $2.51B | $2.06B |
Free Cash Flow OCF − CapEx | $-2.97B | $2.81B | $-1.34B | $-1.37B |
Shares Outstanding | 673.60M | 672.16M | 683.10M | 679.88M |